(c) 2024 PillSync.com

Acetaminophen 325 MG Hydrocodone Bitartrate 10 MG Oral Tablet

INDICATIONS AND USAGE Hydrocodone Bitartrate and Acetaminophen Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see WARNINGS ], reserve Hydrocodone Bitartrate and Acetaminophen Tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): Have not been tolerated or are not expected to be tolerated, Have not provided adequate analgesia or are not expected to provide adequate analgesia Hydrocodone Bitartrate and Acetaminophen Tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.

Lannett Company, Inc.


4 years ago OVAL WHITE LCI 16 51 Acetaminophen 325 MG  Hydrocodone Bitartrate 10 MG Oral Tablet

OVAL WHITE LCI 16 51

HOW SUPPLIED

HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets, USP are supplied as: 5 mg/325 mg off-white to pink, capsule-shaped tablets with red specks debossed with “1649” on one side and “LCI” on the other side. Bottle of 100 NDC 0527-1649-01 Bottle of 500 NDC 0527-1649-05 7.5 mg/325 mg white, oval-shaped, bisected tablets debossed with “1650” on one side and “LCI” on the other side. Bottle of 100 NDC 0527-1650-01 Bottle of 500 NDC 0527-1650-05 10 mg/325 mg white, oval-shaped, bisected tablets debossed with “1651” on one side and “LCI” on the other side. Bottle of 100 NDC 0527-1651-01 Bottle of 500 NDC 0527-1651-05 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Store

HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets securely and dispose of properly [see PRECAUTIONS; Information for Patients ]. Distributed by: Lannett Company, Inc. Philadelphia, PA 19136 CIB71726C Rev. 01/24


More pills like OVAL LCI 16 51












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site